Provided by Tiger Trade Technology Pte. Ltd.

ImmuCell

10.24
+0.34003.43%
Post-market: 10.240.00000.00%16:10 EDT
Volume:29.83K
Turnover:302.10K
Market Cap:92.63M
PE:-169.85
High:10.47
Open:9.93
Low:9.78
Close:9.90
52wk High:10.75
52wk Low:4.52
Shares:9.05M
Float Shares:6.02M
Volume Ratio:0.80
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0603
EPS(LYR):-0.1200
ROE:-1.88%
ROA:4.60%
PB:3.18
PE(LYR):-85.33

Loading ...

ImmuCell Earnings Call Highlights Record Growth Push

TIPRANKS
·
May 16

ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year

Reuters
·
May 15

ImmuCell Q1 FY26 net income rises 34.2% to $1.94 million; product sales climb 28.4% to $10.36 million

Reuters
·
May 15

ImmuCell Q1 EPS $0.21 Up From $0.16 YoY, Sales $10.357M Up From $8.067M YoY

Benzinga
·
May 15

ImmuCell Corporation Q1 EPS USD 0.21

THOMSON REUTERS
·
May 15

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

THOMSON REUTERS
·
May 15

ImmuCell Reaches Settlement Agreement with Norbrook Laboratories

TIPRANKS
·
May 09

BRIEF-ImmuCell, Norbrook Enter Settlement Deed On May 8, 2026 - SEC Filing

Reuters
·
May 09

ImmuCell Corp - Norbrook Agrees to Pay ImmuCell $2 Mln Under Settlement Deed - SEC Filing

THOMSON REUTERS
·
May 09

ImmuCell settles Norbrook dispute, receives $2 million payment

Reuters
·
May 09

ImmuCell publishes update to financial calendar

Reuters
·
May 08

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026

GlobeNewswire
·
May 08

Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report

prnewswire
·
Apr 28

ImmuCell files Form 3 disclosing director Gilles Guillemette stake

Reuters
·
Apr 24

ImmuCell announces annual shareholder meeting via webcast and conference call

Reuters
·
Apr 15

ImmuCell appoints Gilles Guillemette, Anthony DiMarco to board

Reuters
·
Apr 14

Press Release: ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

Dow Jones
·
Apr 14

ImmuCell Q1 Sales Jump; Shares Rise After Hours

MT Newswires Live
·
Apr 09

ImmuCell Q1 product sales rise 28.4% to $10.4 million on Tri-Shield strength

Reuters
·
Apr 09

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

GlobeNewswire
·
Apr 09